
Opinion|Videos|February 24, 2025
Assessing Patient Confidence With Biosimilars
Panelists discuss how health care professionals have varying confidence in biosimilars, driven by concerns about efficacy, safety, and interchangeability. Increased education, real-world evidence, professional engagement, transparent regulations, and comprehensive outcome data can help build trust in these alternative biologic treatments.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How do you view patient confidence with biosimilars so far? What can be done to increase their confidence in biosimilars?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Contributor: Engagement Is the Missing Link in Kidney Care—How Payers and Value-Based Partnerships Can Close the Gap
2
Reactivating CCNA2 Gene Enables Adult Heart Cells to Regenerate
3
Bronchiectasis Hospitalizations Deadlier, Costlier Than Those for COPD, Asthma
4
Long-Term Burdens for SJS/TEN Survivors Highlight Critical Care Gaps
5

















































